RBM47 and its Role in Pancreatic Cancer Progression
Author Information
Author(s): Ma Yihui, Liu Enjie, Fan Huijie, Li Chenfei, Huang Pei, Cui Meiying, Wang Zhengyang, Zhou Jing, Chen Kuisheng
Primary Institution: The First Affiliated Hospital of Zhengzhou University
Hypothesis
RBM47 might affect pancreatic cancer progression by regulating PDIA6.
Conclusion
RBM47 contributes to pancreatic cancer progression by promoting cell proliferation and immune evasion through the upregulation of PDIA6.
Supporting Evidence
- RBM47 overexpression drove pancreatic cancer progression by promoting cell proliferation.
- RBM47 knockdown exhibited the opposite effects on proliferation and immune evasion of pancreatic cancer cells.
- RBM47 was able to bind to the 3′-UTR region of PDIA6, maintaining PDIA6 mRNA stability.
- PDIA6 overexpression reversed the suppressing effects of RBM47 knockdown on cell proliferation and immune evasion.
Takeaway
RBM47 helps pancreatic cancer cells grow and avoid being attacked by the immune system, which could be a target for new treatments.
Methodology
The study used bioinformatics analysis, cell proliferation assays, xenograft models, and metabolomics analysis to investigate the role of RBM47 in pancreatic cancer.
Limitations
The study does not rule out the possibility that other differentially expressed genes might also play a role in pancreatic cancer progression.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website